NFG
VRDN icon

Nations Financial Group’s Viridian Therapeutics VRDN Stock Holding History

Nations Financial Group’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+11,272
New +$182K 0.01% 752

Other funds holding VRDN

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
EC
Eleva Capital Paris, France $343M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Nations Financial Group's VRDN Position: Q2 2026 in Review

Nations Financial Group opened a new position in Viridian Therapeutics (VRDN) in Q2 2026: 11,272 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #752 among its holdings.

22 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • Nations Financial Group held 11,272 shares of Viridian Therapeutics worth $207K as of Q2 2026.
  • Viridian Therapeutics was a new Nations Financial Group position in Q2 2026.
  • Viridian Therapeutics made up 0.01% of Nations Financial Group's portfolio in Q2 2026, its #752 holding.
  • 22 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.